Fibroblastic Reticular Cells From Lymph Nodes Attenuate T Cell Expansion by Producing Nitric Oxide

S Siegert, HY Huang, CY Yang, L Scarpellino, L Carrie, Sarah Essex, PJ Nelson, M Heikenwalder, H Acha-Orbea, Christopher Buckley, BJ Marsland, D Zehn, SA Luther

Research output: Contribution to journalArticlepeer-review

86 Citations (Scopus)
132 Downloads (Pure)


Adaptive immune responses are initiated when T cells encounter antigen on dendritic cells (DC) in T zones of secondary lymphoid organs. T zones contain a 3-dimensional scaffold of fibroblastic reticular cells (FRC) but currently it is unclear how FRC influence T cell activation. Here we report that FRC lines and ex vivo FRC inhibit T cell proliferation but not differentiation. FRC share this feature with fibroblasts from non-lymphoid tissues as well as mesenchymal stromal cells. We identified FRC as strong source of nitric oxide (NO) thereby directly dampening T cell expansion as well as reducing the T cell priming capacity of DC. The expression of inducible nitric oxide synthase (iNOS) was up-regulated in a subset of FRC by both DC-signals as well as interferon-gamma produced by primed CD8+ T cells. Importantly, iNOS expression was induced during viral infection in vivo in both LN FRC and DC. As a consequence, the primary T cell response was found to be exaggerated in Inos(-/-) mice. Our findings highlight that in addition to their established positive roles in T cell responses FRC and DC cooperate in a negative feedback loop to attenuate T cell expansion during acute inflammation.
Original languageEnglish
Article numbere27618
JournalPLoS ONE
Issue number11
Publication statusPublished - 14 Nov 2011


Dive into the research topics of 'Fibroblastic Reticular Cells From Lymph Nodes Attenuate T Cell Expansion by Producing Nitric Oxide'. Together they form a unique fingerprint.

Cite this